Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
19 November 2015
Header
Header image
News

News

Responsible Antibiotics Use is Key to Addressing the Rise of AMR
17 November 2015

On the advent of European Antibiotics Awareness Day, EFPIA takes note of the serious challenges caused by antimicrobial resistance (AMR) and reiterates the industry’s commitment [...] Read more

From our blog

From our blog

IMI JU and EFPIA – New Drugs for Bad Bugs Programme (ND4BB) – Guest Blog
19 November 2015 by Seamus O’Brien

There is now an extensive framework of European collaborative projects (pharmaceutical industry and academia), funded by the Innovative Medicines Initiative (IMI) and EFPIA, which address the challenges of antibiotic resistance. 

Read more

From our blog

How does European data privacy legislation impact on the disclosure code?
19 November 2015 by Julie Bonhomme

In Europe, the Data Protection Regulation requires companies to seek consent from a health professional in order to publish their personal information. In June 2016, EFPIA member companies will publicly disclose payments made to health professionals, including: consultancy, advisory boards, speaker fees and sponsorship to attend meetings.

Read more

From our blog

Donate your data
19 November 2015 by Richard Bergström

Today is Organ Donation Day. Millions of European citizens have signed up to allow their organs to be used for transplantation after they die. My friend Miklós Szócska, former health minister of Hungary, suggested we need the same approach for the use of health data.

Read more

From our blog

Collaborating to End the Blight of Diabetes
19 November 2015 by Magda Chlebus

The statistics on the prevalence of diabetes – a chronic disease in which the body fails to process glucose properly – across the globe are a serious cause for concern. In 2014, the World Health Organization estimated that around 9% of adults across worldwide had this disease. In 2012 1.5 million deaths were directly caused by diabetes and by 2030 the projection is that it is set to be the 7th leading cause of death. These figures represent a significant incentive for the pharmaceutical industry and its partners to address this problem.

Read more

Events calendar

Events Calendar

Emerging Medicinal Products – from laboratory to patient use
On 14/12/2015 (De Vere Centre, 1 Westferry Circus, Canary Wharf, London)

The fourth annual regulatory policy summit has been organised by EBE and the European Medicines Agency (EMA).

 

 

 

Read more

Documents

From our blog

Patient Data: Making clinical research possible - Ethically harnessing data while preserving confidentiality and trust
06 November 2015 (Publications)

Read more

What we are reading

What we are reading

Lives are at stake in data protection talks
19 November 2015 (EU Reporter)

Data protection is currently being discussed in the ‘trilogue’ – the name for the discourse between the European Council, Commission and Parliament – in the run-up to a new Data Protection Regulation.

Now, one of the sticking points of this upcoming new ruling is that the European Parliament seems only to have focused on a blanket protection of personal data, without taking into account the myriad uses this vital information can have for research, especially in the world of medicine.

Read more

What we are reading

The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public–private partnerships for the development of new strategies to tackle antibiotic resistance
19 November 2015 (Oxford Journals)

Antibiotic resistance (ABR) is a global public health threat. Despite the emergence of highly resistant organisms and the huge medical need for new drugs, the development of antibacterials has slowed to an unacceptable level worldwide.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail